Status:
COMPLETED
Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single Doses of AZD8566.
Lead Sponsor:
AstraZeneca
Conditions:
Healthy Volunteer
Eligibility:
All Genders
18-55 years
Phase:
PHASE1
Brief Summary
The purpose of this study is to determine how well tolerated and safe AZD8566 is at different dose levels. This study will also determine how AZD8566 is distributed around the body and how it leaves t...
Eligibility Criteria
Inclusion
- Provision of written informed consent.
- Clinically normal physical findings and laboratory values as judged by the investigator with normal ECG
- Females who are permanently or surgically sterile or postmenopausal.
Exclusion
- Intake of medicine (except Hormone Replacement Therapy or occasional paracetamol) within 3 weeks before first administration of study drug
- History of any convulsions or seizures
- History of infection or at risk of infection due to recent surgery or trauma
- History or presence of conditions known to interfere with the absorption, distribution, metabolism and excretion of the study drug
Key Trial Info
Start Date :
August 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2009
Estimated Enrollment :
108 Patients enrolled
Trial Details
Trial ID
NCT00749333
Start Date
August 1 2008
End Date
February 1 2009
Last Update
April 30 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Nottingham, United Kingdom